John H. Leaman
2013
In 2013, John H. Leaman earned a total compensation of $2M as Chief Financial Officer at Medgenics.
Compensation breakdown
| Bonus | $105,409 |
|---|---|
| Option Awards | $1,825,600 |
| Salary | $110,817 |
| Other | $6,048 |
| Total | $2,047,874 |
Leaman received $1.8M in option awards, accounting for 89% of the total pay in 2013.
Leaman also received $105.4K in bonus, $110.8K in salary and $6K in other compensation.
Rankings
In 2013, John H. Leaman's compensation ranked 3,828th out of 12,286 executives tracked by ExecPay. In other words, Leaman earned more than 68.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,828 out of 12,286 | 69th |
Division Manufacturing | 1,296 out of 4,612 | 72nd |
Major group Chemicals And Allied Products | 350 out of 1,466 | 76th |
Industry group Drugs | 245 out of 1,160 | 79th |
Industry Biological Products, Except Diagnostic Substances | 35 out of 200 | 83rd |
Source: SEC filing on March 11, 2014.
Leaman's colleagues
We found six more compensation records of executives who worked with John H. Leaman at Medgenics in 2013.
2013
Michael Cola
Medgenics
Chief Executive Officer
2013
Garry Neil
Medgenics
Chief Scientific Officer
2013
Andrew Pearlman
Medgenics
Chief Executive Officer
2013
Clarence Dellio
Medgenics
Chief Operating Officer
2013
Marvin Garovoy
Medgenics
Chief Medical Officer
2013
Phyllis Bellin
Medgenics